CONTINUE TO SITE >
OR WAIT 15 SECS
Search
Spotlight
Cataract Therapeutics
Glaucoma Insights
Branded vs Generics
CME Activities
Glaucoma Management
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoints
AMD Awareness
Cataract Therapeutics
Glaucoma Insights
Branded vs Generics
CME Activities
Glaucoma Management
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoints
AMD Awareness
Clinical
View More
Cataract
Clinical Diagnosis
Cornea
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Refractive
Retina
Technology
Therapeutic Cataract & Refractive
Understanding Antibiotic Resistance
Cataract
Clinical Diagnosis
Cornea
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Refractive
Retina
Technology
Therapeutic Cataract & Refractive
Understanding Antibiotic Resistance
News
All News
Blogs
COVID-19
All News
Blogs
COVID-19
Media
Expert Interviews
Medical World News
Podcasts
Viewpoints
Expert Interviews
Medical World News
Podcasts
Viewpoints
Business
Health Law & Policy
Money Matters
Personal Finance
Practice Management
Health Law & Policy
Money Matters
Personal Finance
Practice Management
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Publications
Digital Edition
Europe Ophthalmology Times
Modern Retina
Supplements and Featured Publications
Digital Edition
Europe Ophthalmology Times
Modern Retina
Supplements and Featured Publications
CME/CE
Resources
Job Board
Sponsored
Job Board
Sponsored
Subscribe
eNewsletter
Print Subscription
eNewsletter
Print Subscription
Search
Spotlight
Cataract Therapeutics
Glaucoma Insights
Branded vs Generics
CME Activities
Glaucoma Management
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoints
AMD Awareness
Clinical
See All >
Cataract
Clinical Diagnosis
Cornea
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Refractive
Retina
Technology
Therapeutic Cataract & Refractive
Understanding Antibiotic Resistance
Angle-supported phakic IOL shows good results in high myopia
June 15, 2004
Anterior chamber lens meets or exceeds FDA guidelines in multicenter European trial